2024
Characteristics And Procedural Complications Of Septal Myectomy For Obstructive Hypertrophic Cardiomyopathy In The United States
Altibi A, Elman M, Zhao Y, Chehab J, Butzner M, Heitner S, Jacoby D, Sohn R, Masri A. Characteristics And Procedural Complications Of Septal Myectomy For Obstructive Hypertrophic Cardiomyopathy In The United States. Journal Of Cardiac Failure 2024, 30: 177-178. DOI: 10.1016/j.cardfail.2023.10.149.Peer-Reviewed Original ResearchObstructive hypertrophic cardiomyopathySeptal myectomyBaseline characteristicsHypertrophic cardiomyopathyInpatient complicationsConcomitant mitral valve repairVentricular septal defectMitral valve repairMitral valve replacementPredictor of inpatient complicationsCohort of patientsOutcomes of SMValve repairSeptal defectValve replacementAtrial fibrillation/flutterAnoxic brain damagePacemaker implantationAdult patientsHeart blockCardiac arrestEmergency intubationProcedural outcomesContinuous enrollmentMyectomy
2022
Clinical Outcomes of Revascularization with Percutaneous Coronary Intervention Prior to Transcatheter Aortic Valve Replacement: A Comprehensive Meta-Analysis
Altibi A, Ghanem F, Hammad F, Patel J, Song H, Golwala H, Zahr F, Rahmouni H. Clinical Outcomes of Revascularization with Percutaneous Coronary Intervention Prior to Transcatheter Aortic Valve Replacement: A Comprehensive Meta-Analysis. Current Problems In Cardiology 2022, 47: 101339. PMID: 35908687, DOI: 10.1016/j.cpcardiol.2022.101339.Peer-Reviewed Original ResearchConceptsTranscatheter aortic valve replacementCoexisting coronary artery diseaseIncreased risk of life-threatening bleedingCoronary artery diseaseRisk of life-threatening bleedingLife-threatening bleedingAortic valve replacementOutcomes of revascularizationValve replacementIncreased riskOdds ratioTranscatheter aortic valve replacement patientsSignificant coronary artery diseasePooled estimates of odds ratiosMeta-analysisAcute kidney injuryEstimates of odds ratiosAssociated with improved 30-dayPercutaneous coronary interventionRandom-effects modelNo significant differencePacemaker implantationPost-TAVRKidney injuryClinical outcomes